<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">17803332</PMID>
        <DateCompleted>
            <Year>2007</Year>
            <Month>11</Month>
            <Day>29</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1170-7690</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>25</Volume>
                    <Issue>9</Issue>
                    <PubDate>
                        <Year>2007</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PharmacoEconomics</Title>
                <ISOAbbreviation>Pharmacoeconomics</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The increasingly complex fourth hurdle for pharmaceuticals.</ArticleTitle>
            <Pagination>
                <MedlinePgn>727-34</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>There are three known criteria that underlie drug reimbursement decisions: therapeutic value, cost effectiveness and burden of disease. However, evidence from recent reimbursement decisions in several jurisdictions points to residual unexplained variables, one of which may be budget impact. An economic rationale for carrying out budget impact analyses is opportunity cost, measured by the economic benefits foregone by using resources in one way rather than another. Under certain assumptions, cost-effectiveness analysis accounts for opportunity cost while conveying to the decision maker the price of maximising health gains, subject to a budget constraint. However, the underlying assumptions are implausible, particularly in the context of pharmaceutical care. Although drugs that are cost effective may lead to unambiguous health gains among patient groups for whom the drugs are indicated, the opportunity costs could conceivably lead to a reduction in aggregate health gains, or failure to meet different kinds of equity considerations. The pertinent policy question is where to find the resources to fund new innovations, such as cost-effective pharmaceuticals, or drugs targeting severe diseases. It may be a matter of redeployment of resources across healthcare sectors, cancelling the funding of (older) pharmaceuticals that are less cost effective, or delisting drugs that are cost effective but target less burdensome conditions.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cohen</LastName>
                    <ForeName>Joshua</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tufts Center for Study of Drug Development, Boston, Massachusetts 02111, USA. joshua.cohen@tufts.edu</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stolk</LastName>
                    <ForeName>Elly</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Niezen</LastName>
                    <ForeName>Maartje</ForeName>
                    <Initials>M</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>New Zealand</Country>
            <MedlineTA>Pharmacoeconomics</MedlineTA>
            <NlmUniqueID>9212404</NlmUniqueID>
            <ISSNLinking>1170-7690</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>T</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007349" MajorTopicYN="Y">Insurance, Health, Reimbursement</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007356" MajorTopicYN="Y">Insurance, Pharmaceutical Services</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2007</Year>
                <Month>9</Month>
                <Day>7</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2007</Year>
                <Month>12</Month>
                <Day>6</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2007</Year>
                <Month>9</Month>
                <Day>7</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">17803332</ArticleId>
            <ArticleId IdType="pii">2592</ArticleId>
            <ArticleId IdType="doi">10.2165/00019053-200725090-00002</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>BMJ. 2004 Nov 20;329(7476):1233-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15550430</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2004 Jul 24;329(7459):224-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15271836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Health Econ. 2007 Sep;8(3):253-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17279403</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Value Health. 2003 Jul-Aug;6 Suppl 1:S10-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12846922</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Pharmacoecon Outcomes Res. 2001 Oct;1(1):7-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19807502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Manag Care Pharm. 2007 Jan-Feb;13(1):37-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17269835</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2003 Jan-Jun;Suppl Web Exclusives:W3-28-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14527233</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacoeconomics. 2001;19(11):1103-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11735677</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Appl Health Econ Health Policy. 2006;5(3):177-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17132032</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Health Econ. 2004 Feb;5(1):28-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15452762</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Manag Care Pharm. 2005 Jan-Feb;11(1):66-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15667234</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Health Econ. 2005 Dec;Suppl:53-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16270209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2004 Oct 23;329(7472):972-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15499118</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2003 May-Jun;22(3):42-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12757270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2004 Jan-Feb;23(1):124-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15002635</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CMAJ. 2003 Jul 22;169(2):120-1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12874159</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2000 Mar-Apr;19(2):92-109</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10718025</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Value Health. 2004 Sep-Oct;7(5):518-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15367247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Policy. 2002 Jan;59(1):53-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11786174</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Econ. 2004 Jan;13(1):21-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14724891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Value Health. 2005 Jul-Aug;8(4):433-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16091019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2004 Jul 24;329(7459):227-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15271837</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>QJM. 2005 Nov;98 (11):829-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16203824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacoeconomics. 2005;23(3):219-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15836004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2003 Jul-Dec;Suppl Web Exclusives:W3-537-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15506158</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2006 Jan-Feb;25(1):186-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16403753</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Value Health. 2003 Jul-Aug;6 Suppl 1:S46-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12846925</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Econ. 2004 May;13(5):437-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15127424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Value Health. 2007 Sep-Oct;10(5):336-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17888098</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Technol Assess. 2008 Apr;12 (7):iii, ix-x, 1-175</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18373906</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Soc Sci Med. 2006 May;62(9):2091-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16325975</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
